GLP-1 receptor agonist–induced diabetic ketoacidosis: A case report
This case suggests that clinicians should be alert to patients with severe DKA in cases of severe gastrointestinal adverse reactions after the use of GLP-1RAs. In addition, in most countries, GLP-1RAs are administered to patients with T2D, but we should consider the use of GLP-1RAs in patients with type 1 diabetes and LADA.
Authors
- Jiaming Zhang (ORCID: https://orcid.org/0009-0000-2673-975X)
- Yao Zhang (ORCID: https://orcid.org/0000-0002-1962-8661)
- Ying Ma (ORCID: https://orcid.org/0000-0003-1856-101X)
- Xiaohui Wang (ORCID: https://orcid.org/0009-0009-8481-1540)
- Qianhe Zu
Institutions
- Hebei Medical University (CN)
- Affiliated Hospital of Hebei University (CN)
- Baoding University (CN)
- Hebei University (CN)
Publication Details
- Journal
- Medicine
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1097/md.0000000000039799
- Citations
- 14
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.01